PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12830260::ACT034419

TXM-CB3

Evidence text

Paper-level observation

Fig. 2C: CB3-treated animals showed a robust and sustained reduction in seizure frequency throughout the monitoring period.
textConfidence: medium

Assay observation

Activity
Other
Subtype
Not reported by source
Measure
other
Comparator
=
Raw observation
robust and sustained reduction in seizure frequency throughout the monitoring period
Normalized measurement
Not reported by source
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
ACCPCNH
Standardization
ready simple

Source publication

Thioredoxin-mimetic peptide attenuates epilepsy progression and neurocognitive deficits

Redox Biology · 2026

DOI 10.1016/j.redox.2026.104021 PMC12830260
Parent mention

Related peptide identities

PEPDIA-PLP-000024

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.